News | January 06, 2008

Cook Medical Pays Cardica $2 Million for Milestones

January 7, 2008 - Cardica Inc. received nearly $2 million in payments from Cook Medical (Cook) for reaching milestones pursuant to its development agreements with Cook, including a vascular closure device collaboration agreement and initial development milestone for a device to repair heart defects.

Cardica received the fourth and final milestone payment of $500,000 for the delivery of the Cook Vascular Closure Device (CVCD), an automated system designed to close access openings in femoral arteries after interventional vascular procedures. Cook also paid $1.3 million to Cardica for the successful completion of the first phase of design and development of a specialized device designed to close patent foramen ovales (PFO), genetic heart defects.

Cardica also received a payment of $180,000 from Cook for the initial purchase of parts to build a specific number of these vascular closure devices for commercial use.

Under the agreement for the CVCD, Cardica has received a total of $2.0 million in milestone payments and has expanded this collaboration to include a second product in the vascular closure device product line. Similarly, under the agreement for the PFO closure device, Cardica has received to date $2.15 million in fees and milestone payments and may receive an additional approximately $1.4 million in development milestone payments beyond the $1.3 million announced today. With both products, Cardica is also entitled to receive royalties on any future worldwide sales by Cook, and Cook has exclusive worldwide commercialization and marketing rights.

For more information: www.cookmedical.com and www.cardica.com


Related Content

News | Vascular Closure Devices

April 16, 2024 β€” Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home April 16, 2024
Home
News | Vascular Closure Devices

September 16, 2022 β€” Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr. Magnus ...

Home September 16, 2022
Home
News | Vascular Closure Devices

November 9, 2021 β€” Results from the largest randomized trial available comparing different closure device strategies ...

Home November 09, 2021
Home
News | Vascular Closure Devices

July 15, 2021 β€” Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully ...

Home July 15, 2021
Home
News | Vascular Closure Devices

August 17, 2020 β€” Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure ...

Home August 17, 2020
Home
Videos | Vascular Closure Devices

Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend ...

Home October 17, 2019
Home
Technology | Vascular Closure Devices

April 3, 2019 β€” Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

Home April 03, 2019
Home
Technology | Vascular Closure Devices

December 20, 2018 β€” Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food ...

Home December 20, 2018
Home
News | Vascular Closure Devices

November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for ...

Home November 21, 2018
Home
News | Vascular Closure Devices

November 12, 2018 β€” The Vascade MVP vascular closure system met its endpoints compared to manual compression in a ...

Home November 11, 2018
Home
Subscribe Now